Down-regulation of BMI-1 cooperates with artemisinin on growth inhibition of nasopharyngeal carcinoma cells

Journal of Cellular Biochemistry

Volumn 112, Issue 7, 2011, Pages 1938-1948

  Wu, Jing ^a,b,c   Hu, Dong ^c   Yang, Guang ^a,b   Zhou, Junyi ^a,b   Yang, Changfu ^a,b   Gao, Yun ^a,b   Zhu, Zhenyu ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c ANHUI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Artemisinin; BMI 1; Cell cycle arrest; Nasopharyngeal carcinoma

Indexed keywords

ARTEMISININ; BMI1 PROTEIN; CYCLIN DEPENDENT KINASE 4; PROTEIN P16;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE G1 PHASE; CELL PROLIFERATION; DOWN REGULATION; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; ARTEMISININS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASES; CYCLINS; DOWN-REGULATION; G1 PHASE; GENE EXPRESSION; HUMANS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; RNA INTERFERENCE;

MOLONEY MURINE LEUKEMIA VIRUS; PLASMODIUM FALCIPARUM;

EID: 80051506043     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23114     Document Type: Article

References (47)

1. Baghdassarian N, Ffrench M. 1996. Cyclin-dependent kinase inhibitors (CKIs) and hematological malignancies. Hematol Cell Ther 38:313-323. (Pubitemid 26292504)
2. Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J, Bartek J. 1996. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res 56:5475-5483. (Pubitemid 27011383)
3. Caponigro F, Longo F, Ionna F, Perri F. 2010. Treatment approaches to nasopharyngeal carcinoma: A review. Anticancer Drugs 21:471-477.
4. Chawira AN, Warhurst DC, Robinson BL, Peters W. 1987. The effect of combinations of qinghaosu (artemisinin) with standard antimalarial drugs in the suppressive treatment of malaria in mice. Trans R Soc Trop Med Hyg 81:554-558. (Pubitemid 17121105)
5. Chen HH, Zhou HJ, Wu GD, Lou XE. 2004. Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1. Pharmacology 71:1-9.
6. Chen H, Sun B, Wang S, Pan S, Gao Y, Bai X, Xue D. 2010. Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: Involvement of cell cycle arrest and inactivation of nuclear factor-kappaB. J Cancer Res Clin Oncol 136:897-903.
7. Dhawan S, Tschen SI, Bhushan A. 2009. Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. Genes Dev 23:906-911.
8. Dutta GP, Bajpai R, Vishwakarma RA. 1989. Artemisinin (qinghaosu)-A new gametocytocidal drug for malaria. Chemotherapy 35:200-207. (Pubitemid 19161234)
9. Efferth T. 2006. Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells. Curr Drug Targets 7:407-421. (Pubitemid 43744832)
10. Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR. 2001. The antimalarial artesunate is also active against cancer. Int J Oncol 18:767-773.
11. Efferth T, Benakis A, Romero MR, Tomicic M, Rauh R, Steinbach D, Hafer R, Stamminger T, Oesch F, Kaina B, Marschall M. 2004. Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Radic Biol Med 37:998-1009. (Pubitemid 39164582)
12. Ferguson KL, Callaghan SM, O'Hare MJ, Park DS, Slack RS. 2000. The Rb- CDK4/6 signaling pathway is critical in neural precursor cell cycle regulation. J Biol Chem 275:33593-33600.
13. Firestone GL, Sundar SN. 2009. Anticancer activities of artemisinin and its bioactive derivatives. Expert Rev Mol Med 11:e32.
14. Gravett AM, Liu WM, Krishna S, Chan WC, Haynes RK, Wilson NL, Dalgleish AG. 2010. In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents. Cancer Chemother Pharmacol 6:569-577.
15. Guo WJ, Datta S, Band V, Dimri GP. 2007. Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins. Mol Biol Cell 18:536-546. (Pubitemid 46213222)
16. Haupt Y, Alexander WS, Barri G, Klinken SP, Adams JM. 1991. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell 65:753-763. (Pubitemid 121001307)
17. He Y, Fan J, Lin H, Yang X, Ye Y, Liang L, Zhan Z, Dong X, Sun L, Xu H. 2009a. The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1alpha in human rheumatoid arthritis fibroblast-like synoviocyte. Rheumatol Int 31:53-60.
18. He S, Iwashita T, Buchstaller J, Molofsky AV, Thomas D, Morrison SJ. 2009b. Bmi-1 over-expression in neural stem/progenitor cells increases proliferation and neurogenesis in culture but has little effect on these functions in vivo. Dev Biol 328:257-272.
19. Hirai H, Roussel MF, Kato JY, Ashmun RA, Sherr CJ. 1995. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol 15:2672-2681.
20. Hou J, Wang D, Zhang R, Wang H. 2008. Experimental therapy of hepatoma with artemisinin and its derivatives: In vitro and in vivo activity, chemosensitization, and mechanisms of action. Clin Cancer Res 14:5519-5530.
21. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M. 1999. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 97:164-168. (Pubitemid 29050921)
22. Jayaprakasam B, Seeram NP, Nair MG. 2003. Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana. Cancer Lett 189: 11-16. (Pubitemid 35351514)
23. Jin CY, Kim GY, Choi YH. 2008. Induction of apoptosis by aqueous extract of Cordyceps militaris through activation of caspases and inactivation of Akt in human breast cancer MDA-MB-231 Cells. J Microbiol Biotechnol 18:1997-2003.
24. Klayman DL. 1985. Qinghaosu (artemisinin): An antimalarial drug from China. Science 228:1049-1055. (Pubitemid 15227365)
25. Lo KW, Huang DP. 2002. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 12:451-462. (Pubitemid 35370758)
26. Luo XD, Shen CC. 1987. The chemistry, pharmacology, and clinical applications of qinghaosu (artemisinin) and its derivatives. Med Res Rev 7:29-52.
27. Mayol X, Garriga J, Grana X. 1996. G1 cyclin/CDK-independent phosphorylation and accumulation of p130 during the transition from G1 to G0 lead to its association with E2F-4. Oncogene 13:237-246. (Pubitemid 26334855)
28. Miao Y, Xiao B, Jiang Z, Guo Y, Mao F, Zhao J, Huang X, Guo J. 2009. Growth inhibition and cell-cycle arrest of human gastric cancer cells by Lycium barbarum polysaccharide. Med Oncol 27:785-790.
29. Molofsky AV, He S, Bydon M, Morrison SJ, Pardal R. 2005. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev 19:1432-1437. (Pubitemid 41003009)
30. Morrissey C, Gallis B, Solazzi JW, Kim BJ, Gulati R, Vakar-Lopez F, Goodlett DR, Vessella RL, Sasaki T. 2010. Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells. Anticancer Drugs 21:423-432.
31. Nakase I, Gallis B, Takatani-Nakase T, Oh S, Lacoste E, Singh NP, Goodlett DR, Tanaka S, Futaki S, Lai H, Sasaki T. 2009. Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis. Cancer Lett 274:290-298.
32. Reed SI, Bailly E, Dulic V, Hengst L, Resnitzky D, Slingerland J. 1994. G1 control in mammalian cells. J Cell Sci Suppl 18:69-73.
33. Riganti C, Doublier S, Viarisio D, Miraglia E, Pescarmona G, Ghigo D, Bosia A. 2009. Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression. Br J Pharmacol 156:1054-1066.
34. Ruan L, Wang GL, Yi H, Chen Y, Tang CE, Zhang PF, Li MY, Li C, Peng F, Li JL, Chen ZC, Xiao ZQ. 2010. Erratum: Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy. J Cell Biochem 110:975-984.
35. Silva J, Garcia JM, Pena C, Garcia V, Dominguez G, Suarez D, Camacho FI, Espinosa R, Provencio M, Espana P, Bonilla F. 2006. Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas. Clin Cancer Res 12:6929-6936. (Pubitemid 44974485)
36. Singh NP, Lai HC. 2004. Artemisinin induces apoptosis in human cancer cells. Anticancer Res 24:2277-2280. (Pubitemid 39166306)
37. Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, Shao JY, Wu QL, Li MZ, Xia YF, Fu LW, Huang WL, Dimri GP, Band V, Zeng YX. 2006. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 66:6225-6232.
38. Styczynski J, Drewa T. 2007. Leukemic stem cells: From metabolic pathways and signaling to a new concept of drug resistance targeting. Acta Biochim Pol 54:717-726.
39. Tao Q, Chan AT. 2007. Nasopharyngeal carcinoma: Molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 9:1-24. (Pubitemid 47398642)
40. Teng ZP, Ooka T, Huang DP, Zeng Y. 1996. Detection of Epstein-Barr virus DNA in well and poorly differentiated nasopharyngeal carcinoma cell lines. Virus Genes 13:53-60. (Pubitemid 26377625)
41. Wang Q, Li WL, You P, Su J, Zhu MH, Xie DF, Zhu HY, He ZY, Li JX, Ding XY, Wang X, Hu YP. 2009. Oncoprotein βMI-1 induces the malignant transformation of HaCaT cells. J Cell Biochem 106:16-24.
42. Willoughby JA, Sr., Sundar SN, Cheung M, Tin AS, Modiano J, Firestone GL. 2009. Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression. J Biol Chem 284:2203-2213.
43. Yang H, Landis-Piwowar KR, Chen D, Milacic V, Dou QP. 2008. Natural compounds with proteasome inhibitory activity for cancer prevention and treatment. Curr Protein Pept Sci 9:227-239. (Pubitemid 351997839)
44. Ye F, Jiang S, Volshonok H, Wu J, Zhang DY. 2007. Molecular mechanism of anti-prostate cancer activity of Scutellaria baicalensis extract. Nutr Cancer 57:100-110. (Pubitemid 46871574)
45. Yokota T, Matsuzaki Y, Koyama M, Hitomi T, Kawanaka M, Enoki-KonishiM, Okuyama Y, Takayasu J, Nishino H, Nishikawa A, Osawa T, Sakai T. 2007. Sesamin, a lignan of sesame, down-regulates cyclin D1 protein expression in human tumor cells. Cancer Sci 98:1447-1453. (Pubitemid 47241769)
46. Young LS, Murray PG. 2003. Epstein-Barr virus and oncogenesis: From latent genes to tumours. Oncogene 22:5108-5121. (Pubitemid 37059592)
47. Zhu JY, Lavrik IN, Mahlknecht U, Giaisi M, Proksch P, Krammer PH, Li-Weber M. 2007. The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen-activated protein kinase activities. Int J Cancer 121:1839-1846. (Pubitemid 47417305)